Trial Profile

Minimally Invasive Surgery and rtPA for Intracerebral Hemorrhage Evacuation

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 03 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Alteplase (Primary)
Indications Intracranial haemorrhages
Focus Adverse reactions; Therapeutic Use
Acronyms MISTIE

Most Recent Events

20 Nov 2013 Results assessing the changes in haematoma and oedema volume presented at the 86th Annual Scientific Sessions of the American Heart Association.
07 Feb 2013 Results presented at the 38th International Stroke Conference.
11 Sep 2012 New source identified and integrated (ISRCTN: Current Controlled Trials; 50142667).

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com